Literature DB >> 26325119

Ocular delivery systems for topical application of anti-infective agents.

Linda Duxfield1, Rubab Sultana1, Ruokai Wang1, Vanessa Englebretsen1, Samantha Deo1, Ilva D Rupenthal2, Raida Al-Kassas1.   

Abstract

For the treatment of anterior eye segment infections using anti-infective agents, topical ocular application is the most convenient route of administration. However, topical delivery of anti-infective agents is associated with a number of problems and challenges owing to the unique structure of the eye and the physicochemical properties of these compounds. Topical ocular drug delivery systems can be classified into two forms: conventional and non-conventional. The efficacy of conventional ocular formulations is limited by poor corneal retention and permeation resulting in low ocular bioavailability. Recently, attention has been focused on improving topical ocular delivery of anti-infective agents using advanced drug delivery systems. This review will focus on the challenges of efficient topical ocular delivery of anti-infective agents and will discuss the various types of delivery systems used to improve the treatment anterior segment infections.

Entities:  

Keywords:  Anti-infective agents; conventional ocular formulations; ocular delivery; particulate systems; polymers

Mesh:

Substances:

Year:  2015        PMID: 26325119     DOI: 10.3109/03639045.2015.1070171

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

1.  Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-β-Cyclodextrin Nanofibers for Ophthalmic Delivery.

Authors:  Xiaoyi Sun; Zhenwei Yu; Zhengyuan Cai; Lingyan Yu; Yuanyuan Lv
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

2.  Tailored nanostructured platforms for boosting transcorneal permeation: Box-Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization.

Authors:  Ibrahim Elsayed; Sinar Sayed
Journal:  Int J Nanomedicine       Date:  2017-10-30

3.  Chitosan Derivatives with Mucoadhesive and Antimicrobial Properties for Simultaneous Nanoencapsulation and Extended Ocular Release Formulations of Dexamethasone and Chloramphenicol Drugs.

Authors:  Aikaterini Karava; Maria Lazaridou; Stavroula Nanaki; Georgia Michailidou; Evi Christodoulou; Margaritis Kostoglou; Hermis Iatrou; Dimitrios N Bikiaris
Journal:  Pharmaceutics       Date:  2020-06-26       Impact factor: 6.321

4.  Comparative Assessment of Distribution Characteristics and Ocular Pharmacokinetics of Norvancomycin Between Continuous Topical Ocular Instillation and Hourly Administration of Eye Drop.

Authors:  Wenxiang Lin; Libei Zhao; Xuetao Huang; Qian Tan; Manqiang Peng; Muhammad Ahmad Khan; Ding Lin
Journal:  Drug Des Devel Ther       Date:  2020-02-26       Impact factor: 4.162

5.  Design and Development of Antibacterial/Anti-inflammatory Dual Drug-Loaded Nanofibrous Inserts for Ophthalmic Sustained Delivery of Gentamicin and Methylprednisolone: In Vitro Bioassay, Solvent, and Method Effects' Evaluation.

Authors:  Shahla Mirzaeei; Donya Barfar
Journal:  Adv Pharm Bull       Date:  2021-07-04

6.  Development and Optimization of Ciprofloxacin HCl-Loaded Chitosan Nanoparticles Using Box-Behnken Experimental Design.

Authors:  Noha M Soliman; Faiyaz Shakeel; Nazrul Haq; Fars K Alanazi; Sultan Alshehri; Mohsen Bayomi; Ahmed S M Alenazi; Ibrahim A Alsarra
Journal:  Molecules       Date:  2022-07-13       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.